Those of you with wet AMD – especially those of you who are getting injections of anti-VEGF medications – are praying for the time when you will not need them or you will not need them as often. When the research on a topical treatment ‘failed’ (Squalamine eye drops used with Lucentis injections to reduce the frequency of injections), the news was disappointing. However, as with many studies, there was a secondary goal which was to improve visual acuity. About that, Sue writes that “31% of the people with ‘classic’ wet AMD lesions gained 11 letters on the chart!” She says…
Start at the beginning…
Are these pages the first ones that you’ve read in Sue’s Journal of her Journey with AMD? We recommend that you read “In the Beginning”.